{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:53:36Z","timestamp":1787241216362,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T00:00:00Z","timestamp":1458345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s11255-016-1264-5","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T03:51:26Z","timestamp":1458359486000},"page":"993-999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"48","author":[{"given":"Chia-En","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Shen","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chi","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-In","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Pei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsiung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,19]]},"reference":[{"key":"1264_CR1","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2006.07.1290","volume":"24","author":"CN Sternberg","year":"2006","unstructured":"Sternberg CN (2006) Are nomograms better than currently available stage groupings for bladder cancer? J Clin Oncol 24:3819\u20133820","journal-title":"J Clin Oncol"},{"key":"1264_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756287211431976","volume":"4","author":"A Anastasiadis","year":"2012","unstructured":"Anastasiadis A, de Reijke TM (2012) Best practice in the treatment of nonmuscle invasive bladder cancer. Ther Adv Urol 4:13\u201332","journal-title":"Ther Adv Urol"},{"key":"1264_CR3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","volume":"64","author":"M Babjuk","year":"2013","unstructured":"Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64:639\u2013653","journal-title":"Eur Urol"},{"key":"1264_CR4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013477","journal-title":"Eur Urol"},{"key":"1264_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1590\/S1677-55382007000300006","volume":"33","author":"AA Antunes","year":"2007","unstructured":"Antunes AA, Nesrallah LJ, Dall\u2019Oglio MF et al (2007) The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy. Int Braz J Urol 33:339\u2013345","journal-title":"Int Braz J Urol"},{"key":"1264_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.urolonc.2014.06.010","volume":"33","author":"R Mano","year":"2015","unstructured":"Mano R, Baniel J, Shoshany O et al (2015) Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer. Urol Oncol 33:67","journal-title":"Urol Oncol"},{"key":"1264_CR7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1681\/ASN.2008090998","volume":"20","author":"G Wong","year":"2009","unstructured":"Wong G, Hayen A, Chapman JR et al (2009) Association of CKD and cancer risk in older people. J Am Soc Nephrol 20:1341\u20131350","journal-title":"J Am Soc Nephrol"},{"key":"1264_CR8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0970-1591.82844","volume":"27","author":"R Ayyathurai","year":"2011","unstructured":"Ayyathurai R, Soloway MS (2011) Monitoring of the upper urinary tract in patients with bladder cancer. Indian J Urol 27:238\u2013244","journal-title":"Indian J Urol"},{"key":"1264_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106:124","journal-title":"J Natl Cancer Inst"},{"key":"1264_CR10","first-page":"3344","volume":"7","author":"Z Huang","year":"2014","unstructured":"Huang Z, Xu R, Lv C et al (2014) A chronic obstructive pulmonary disease negatively influences the prognosis of patients with bladder urothelial carcinoma via hypoxia inducible factor-1\u03b1. Int J Clin Exp Med 7:3344\u20133353","journal-title":"Int J Clin Exp Med"},{"key":"1264_CR11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.urolonc.2014.05.009","volume":"32","author":"S Rausch","year":"2014","unstructured":"Rausch S, Hennenlotter J, Todenhofer T et al (2014) Impaired estimated glomerular filtration rate is a significant predictor for non-muscle-invasive bladder cancer recurrence and progression\u2014introducing a novel prognostic model for bladder cancer recurrence. Urol Oncol 32:1178\u20131183","journal-title":"Urol Oncol"},{"key":"1264_CR12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.eursup.2009.06.010","volume":"8","author":"AG Heijden van der","year":"2009","unstructured":"van der Heijden AG, Witjes JA (2009) Recurrence, progression, and follow-up in non-muscle-invasive bladder cancer. Eur Urol 8:556\u2013562","journal-title":"Eur Urol"},{"key":"1264_CR13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1590\/S1677-55382012000400006","volume":"38","author":"O Gulpinar","year":"2012","unstructured":"Gulpinar O, Halilioglu AH, Gokce MI et al (2012) The value of perioperative mitomycin C instillation in improving subsequent bacillus calmette\u2013guerin instillation efficacy in intermediate and high-risk patients with non-muscle invasive bladder cancer: a prospective randomized study. Int Braz J Urol 38:474\u2013479","journal-title":"Int Braz J Urol"},{"key":"1264_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2011.05.033","volume":"60","author":"J Fernandez-Gomez","year":"2011","unstructured":"Fernandez-Gomez J, Madero R, Solsona E et al (2011) The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette\u2013Guerin: external validation of the EORTC risk tables. Eur Urol 60:423\u2013430","journal-title":"Eur Urol"},{"key":"1264_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","volume":"72","author":"AS Levey","year":"2007","unstructured":"Levey AS, Atkins R, Coresh J et al (2007) Chronic kidney disease as a global public health problem: approaches and initiatives\u2014a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72:247\u2013259","journal-title":"Kidney Int"},{"key":"1264_CR16","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.09011010","volume":"6","author":"PH Weng","year":"2011","unstructured":"Weng PH, Hung KY, Huang HL et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6:1121\u20131128","journal-title":"Clin J Am Soc Nephrol"},{"key":"1264_CR17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","volume":"4","author":"BL Kasiske","year":"2004","unstructured":"Kasiske BL, Snyder JJ, Gilbertson DT, Wang C (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4:905\u2013913","journal-title":"Am J Transplant"},{"key":"1264_CR18","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","volume":"116","author":"BR Lane","year":"2010","unstructured":"Lane BR, Smith AK, Larson BT et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116:2967\u20132973","journal-title":"Cancer"},{"key":"1264_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.21756","volume":"54","author":"AP Grollman","year":"2013","unstructured":"Grollman AP (2013) Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ Mol Mutagen 54:1\u20137","journal-title":"Environ Mol Mutagen"},{"key":"1264_CR20","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.11691","volume":"98","author":"CH Kang","year":"2003","unstructured":"Kang CH, Yu TJ, Hsieh HH et al (2003) The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98:1620\u20131626","journal-title":"Cancer"},{"key":"1264_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jjco\/hyp143","volume":"40","author":"CH Kang","year":"2010","unstructured":"Kang CH, Chen CH, Chiang PH (2010) Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up. Jpn J Clin Oncol 40:241\u2013246","journal-title":"Jpn J Clin Oncol"},{"key":"1264_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.jrn.2011.10.020","volume":"22","author":"ND Vaziri","year":"2012","unstructured":"Vaziri ND, Pahl MV, Crum A et al (2012) Effect of uremia on structure and function of immune system. J Ren Nutr 22:149\u2013156","journal-title":"J Ren Nutr"},{"key":"1264_CR23","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/cncr.22557","volume":"109","author":"CH Chang","year":"2007","unstructured":"Chang CH, Yang CM, Yang AH (2007) Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer 109:1487\u20131492","journal-title":"Cancer"},{"key":"1264_CR24","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1200\/JCO.2010.33.8152","volume":"29","author":"TR Neves","year":"2011","unstructured":"Neves TR, Soares MJ, Monteiro PG (2011) Basaloid squamous cell carcinoma in the urinary bladder with small-cell carcinoma. J Clin Oncol 29:e440-2\u2013e442","journal-title":"J Clin Oncol"},{"key":"1264_CR25","first-page":"989458","volume":"2014","author":"LJ Wang","year":"2014","unstructured":"Wang LJ, Lee SY, Teh BT et al (2014) Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge. Biomed Res Int 2014:989458","journal-title":"Biomed Res Int"},{"key":"1264_CR26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","volume":"62","author":"J Palou","year":"2012","unstructured":"Palou J, Sylvester RJ, Faba OR et al (2012) Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus calmette\u2013guerin. Eur Urol 62:118\u2013125","journal-title":"Eur Urol"},{"key":"1264_CR27","first-page":"1471","volume":"31","author":"T Onishi","year":"2011","unstructured":"Onishi T, Sasaki T, Hoshina A, Yabana T (2011) Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor. Anticancer Res 31:1471\u20131474","journal-title":"Anticancer Res"},{"key":"1264_CR28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2490-14-5","volume":"14","author":"H Kobayashi","year":"2014","unstructured":"Kobayashi H, Kikuchi E, Mikami S et al (2014) Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression. BMC Urol 14:5","journal-title":"BMC Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1264-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-016-1264-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1264-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T08:02:09Z","timestamp":1559376129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-016-1264-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,19]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s11255-016-1264-5","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,19]]}}}